Viewing StudyNCT00138840



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00138840
Status: COMPLETED
Last Update Posted: 2008-12-04
First Post: 2005-08-26

Brief Title: Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohns Disease
Sponsor:
Organization: Synta Pharmaceuticals Corp

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 282
Enrollment Type: None
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: